Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort

Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort

ABSTRACT: Objectives: We aimed to evaluate the prevalence and characteristics of people living with HIV (PLWH) eligible for the long-acting injectable (LAI) regimen with cabotegravir (CAB) and rilpivirine (RPV), in comparison with ineligible individuals. Methods: This was an observational, cross-se...

Full description

Bibliographic Details
Main Authors: Adriana Cervo, Antonio Russo, Domenico Di Carlo, Andrea De Vito, Lavinia Fabeni, Stefano D'Anna, Leonardo Duca, Agnese Colpani, Marco Fois, Beatrice Zauli, Giulia Mancarella, Anna Carraro, Antonia Bezenchek, Alessandro Cozzi-Lepri, Maria Mercedes Santoro
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Long-acting
Cabotegravir
Rilpivirine
HIV
Antiretroviral therapy
Drug resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716523001108

Internet

http://www.sciencedirect.com/science/article/pii/S2213716523001108

Similar Items